ARTICLE | Clinical News
Zinapar darinaparsin regulatory update
September 27, 2010 7:00 AM UTC
FDA granted Orphan Drug designation for Ziopharm's Zinapar darinaparsin to treat peripheral T cell lymphoma (PTCL). The company said it plans to "imminently" begin Phase I testing of the oral organic ...